GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biosino Bio-Technology and Science Inc (HKSE:08247) » Definitions » Return-on-Tangible-Asset

Biosino Bio-Technology and Science (HKSE:08247) Return-on-Tangible-Asset : -4.23% (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Biosino Bio-Technology and Science Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Biosino Bio-Technology and Science's annualized Net Income for the quarter that ended in Dec. 2023 was HK$-24.7 Mil. Biosino Bio-Technology and Science's average total tangible assets for the quarter that ended in Dec. 2023 was HK$584.6 Mil. Therefore, Biosino Bio-Technology and Science's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was -4.23%.

The historical rank and industry rank for Biosino Bio-Technology and Science's Return-on-Tangible-Asset or its related term are showing as below:

HKSE:08247' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -15.91   Med: 0.31   Max: 4.12
Current: -2.13

During the past 13 years, Biosino Bio-Technology and Science's highest Return-on-Tangible-Asset was 4.12%. The lowest was -15.91%. And the median was 0.31%.

HKSE:08247's Return-on-Tangible-Asset is ranked better than
57.14% of 231 companies
in the Medical Diagnostics & Research industry
Industry Median: -9.45 vs HKSE:08247: -2.13

Biosino Bio-Technology and Science Return-on-Tangible-Asset Historical Data

The historical data trend for Biosino Bio-Technology and Science's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosino Bio-Technology and Science Return-on-Tangible-Asset Chart

Biosino Bio-Technology and Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.91 0.46 -0.20 1.34 -2.08

Biosino Bio-Technology and Science Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.20 -3.64 -0.21 -0.41 -4.23

Competitive Comparison of Biosino Bio-Technology and Science's Return-on-Tangible-Asset

For the Diagnostics & Research subindustry, Biosino Bio-Technology and Science's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosino Bio-Technology and Science's Return-on-Tangible-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biosino Bio-Technology and Science's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Biosino Bio-Technology and Science's Return-on-Tangible-Asset falls into.



Biosino Bio-Technology and Science Return-on-Tangible-Asset Calculation

Biosino Bio-Technology and Science's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-12.74/( (641.523+584.584)/ 2 )
=-12.74/613.0535
=-2.08 %

Biosino Bio-Technology and Science's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=-24.74/( (0+584.584)/ 1 )
=-24.74/584.584
=-4.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2023) net income data.


Biosino Bio-Technology and Science  (HKSE:08247) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Biosino Bio-Technology and Science Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Biosino Bio-Technology and Science's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosino Bio-Technology and Science (HKSE:08247) Business Description

Traded in Other Exchanges
N/A
Address
No. 27 Chaoqian Road, Science and Technology Industrial Park, Changping District, Beijing, CHN, 102200
Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of in-vitro diagnostic (IVD) reagent products. the company's revenue is generated from customers located in Mainland China.
Executives
Beijing Enterprises Group Company Limited 2201 Interest of corporation controlled by you
Beijing Enterprises Holdings Limited 2101 Beneficial owner
Hk Zhixin Investment Co., Ltd. 2101 Beneficial owner
Li Dongfeng 2201 Interest of corporation controlled by you
Yan Kang 2201 Interest of corporation controlled by you
Qiu Zhe Feng 2201 Interest of corporation controlled by you
Hai Nan Zhi Xin Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Yun Nan Sheng Neng Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Li Yang Yi Xiong 2201 Interest of corporation controlled by you

Biosino Bio-Technology and Science (HKSE:08247) Headlines

No Headlines